Advanced MR Techniques for Preoperative Glioma Characterization: Part 2

Authors	HANGEL Gilbert SCHMITZ-ABECASSIS Barbara SOLLMANN Nico PINTO Joana ARZANFOROOSH Fatemehsadat BARKHOF Frederik BOOTH Thomas CALVO-IMIRIZALDU Marta CASSIA Guilherme CHMELIK Marek CLEMENT Patricia ERCAN Ece FERNANDEZ-SEARA Maria A FURTNER Julia FUSTER-GARCIA Elies GRECH-SOLLARS Matthew GUVEN N Tugay HATAY Gokce Hale KARAMI Golestan KEIL Vera C KIM Mina KOEKKOEK Johan A F KUKRAN Simran MANCINI Laura NECHIFOR Ruben Emanuel OZCAN Alpay OZTURK-ISIK Esin PISKIN Senol SCHMAINDA Kathleen M SVENSSON Siri F TSENG Chih-Hsien UNNIKRISHNAN Saritha VOS Frans WARNERT Esther ZHAO Moss Y JANČÁLEK Radim NUNES Teresa HIRSCHLER Lydiane SMITS Marion PETR Jan EMBLEM Kyrre E
Year of publication	2023
Type	Article in Periodical
Magazine / Source	Journal of Magnetic Resonance Imaging
MU Faculty or unit	Faculty of Medicine
Citation
Web	https://onlinelibrary.wiley.com/doi/10.1002/jmri.28663
Doi	http://dx.doi.org/10.1002/jmri.28663
Keywords	glioma; brain; preoperative; contrasts; GliMR 2; 0; level of clinical validation
Description	Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this second part, we review magnetic resonance spectroscopy (MRS), chemical exchange saturation transfer (CEST), susceptibility-weighted imaging (SWI), MRI-PET, MR elastography (MRE), and MR-based radiomics applications. The first part of this review addresses dynamic susceptibility contrast (DSC) and dynamic contrast-enhanced (DCE) MRI, arterial spin labeling (ASL), diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting (MRF). Evidence Level3. Technical EfficacyStage 2.